iSpecimen Inc. 8-K

What Happened

• iSpecimen Inc. announced in an 8-K that its 2025 Annual Meeting of Stockholders, first convened on December 31, 2025, was adjourned because a quorum was not achieved.
• The meeting reconvened on January 23, 2026 but was again adjourned for the same reason. The company intends to reconvene the Annual Meeting on February 13, 2026.
• The adjournments were to allow additional time for stockholders to vote on the proposals described in the company’s definitive proxy statement filed with the SEC on November 21, 2025. The record date remains November 3, 2025.

Key Details

• First convened: December 31, 2025 — adjourned for lack of quorum.
• Reconvened: January 23, 2026 — again adjourned for lack of quorum.
• Next planned reconvening: February 13, 2026.
• Record date for shareholder eligibility: November 3, 2025; proposals referenced are those in the Nov 21, 2025 definitive proxy.

Why It Matters

• For investors, repeated adjournments delay shareholder votes on governance matters (e.g., director elections, proxy proposals) and postpone final outcomes tied to those votes.
• The filing contains no financial results, officer changes, or new business transactions—this is a procedural update about the meeting schedule and shareholder voting.
• Shareholders who wish to vote should verify their voting status by the Nov. 3, 2025 record date and monitor any additional communications from iSpecimen about voting methods or supplemental proxy solicitations.